Search

PharmaAthene gets $5.8M Add-on from DoD for Protexia

The Defense Department is awarding another $5.8 million to PharmAthene [PIP] for continued development of Protexia, the company's broad spectrum nerve agent prophylaxis. PharmaAthene in Sept. 2006 received a potential $213 million contract from the Army Space and Missile Command for advanced development of Protexia. As a prophylactic Protexia may reduce or eliminate the need for post-exposure therapeutics.

Subscriber-only content. Please log in below.

Not a subscriber or registered user yet?

Please contact us at clientservices@accessintel.com or call us at 888-707-5814 (Monday – Thursday 9:00 a.m. – 5:30 p.m. and Friday 9:00 a.m. – 3:00 p.m. ET.), to start a free trial, get pricing information, order a reprint, or post an article link on your website.

Congress Updates

Warren And Sheehy Renew Call for “Right to Repair” In NDAA

Sen. Elizabeth Warren (D-Mass.) and Sen. Timothy Sheehy (R-Mont.), two members of the Senate Armed Services Committee (SASC), are renewing their call for “Right to Repair” language in the National […]


HASC Looks To Restrict USV Deliveries Without Navy CONOPS And Strategy

The House Armed Services Committee’s (HASC) fiscal year 2027 defense policy draft bill aims to restrict the Navy’s use of unmanned surface vessels (USV) until it decides on key factors […]


Gaps In Army’s Tactical Counter-Drone Capabilities Remain Concern Of HASC

A draft defense policy bill released this week says the Army is fielding counter-drone capabilities for defense of fixed sites and maneuver forces but suggests that troops at the lowest […]


HASC Wants Closer Look At Army’s SBMC Program, Cites Avoiding Past IVAS Missteps

The House Armed Services Committee (HASC) wants a closer look at the Army’s Soldier Borne Mission Command (SBMC) effort, citing support for the development program while expressing caution to avoid […]